| scholarly article | Q13442814 |
| P50 | author | Andrea Natali | Q37380762 |
| Allan Flyvbjerg | Q49252518 | ||
| Eleuterio Ferrannini | Q59193801 | ||
| P2093 | author name string | A Mitrakou | |
| R Gabriel | |||
| A Golay | |||
| E Muscelli | |||
| K Hojlund | |||
| Relationship between Insulin Sensitivity and Cardiovascular Disease Risk (RISC) Project Investigators | |||
| P2860 | cites work | Glucagon secretion in relation to insulin sensitivity in healthy subjects | Q33229818 |
| Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo | Q33637026 | ||
| Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus | Q35552583 | ||
| beta-cell function in obesity: effects of weight loss. | Q35961983 | ||
| Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains | Q36721554 | ||
| Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). | Q37371843 | ||
| The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives | Q38463027 | ||
| Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction? | Q38765199 | ||
| What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism | Q40730544 | ||
| Insulin action and substrate competition | Q40812874 | ||
| How to measure insulin sensitivity | Q40837713 | ||
| Circulating proinsulin in patients with maturity onset diabetes | Q40864342 | ||
| Adiposity compared with physical inactivity and risk of type 2 diabetes in women | Q43670592 | ||
| Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study | Q43935522 | ||
| Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women | Q44427238 | ||
| Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus | Q46161786 | ||
| Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells | Q46635811 | ||
| Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians | Q51023388 | ||
| Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. | Q51556021 | ||
| Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. | Q54104864 | ||
| Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. | Q54277408 | ||
| Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications | Q59489258 | ||
| Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus | Q68917267 | ||
| Transient hepatic response to glucagon in man: role of insulin and hyperglycemia | Q70223364 | ||
| Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q74124986 | ||
| Glucagon chronically impairs hepatic and muscle glucose disposal | Q79389968 | ||
| Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes | Q83207597 | ||
| P433 | issue | 11 | |
| P921 | main subject | glucagon | Q28163629 |
| insulin resistance | Q1053470 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 2342-2347 | |
| P577 | publication date | 2007-09-11 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Association of fasting glucagon and proinsulin concentrations with insulin resistance. | |
| P478 | volume | 50 |
| Q33858409 | A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. |
| Q56982053 | Contribution of Pancreatic Alpha Cell Function to Insulin Sensitivity and Glycemic Variability in Patients with Type 1 Diabetes |
| Q90119101 | Effect of flaxseed oil on muscle protein loss and carbohydrate oxidation impairment in a pig model after lipopolysaccharide challenge |
| Q53683154 | Exercise Increases Insulin Sensitivity and Skeletal Muscle AMPK Expression in Systemic Lupus Erythematosus: A Randomized Controlled Trial. |
| Q89656191 | Fasting glucagon concentrations are associated with longitudinal decline of β-cell function in non-diabetic humans |
| Q64078235 | Glucose-dependent Insulinotropic Polypeptide (GIP) Resistance and β-cell Dysfunction Contribute to Hyperglycaemia in Acromegaly |
| Q37283982 | Growth factor control of pancreatic islet regeneration and function |
| Q48019532 | Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients. |
| Q42557992 | Hypoglycemic effect of Chlorella vulgaris intake in type 2 diabetic Goto-Kakizaki and normal Wistar rats |
| Q38636706 | Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk. |
| Q37531511 | Impact of obesity severity and duration on pancreatic β- and α-cell dynamics in normoglycemic non-human primates. |
| Q35034772 | Impact of three oral antidiabetic drugs on markers of β-cell function in patients with type 2 diabetes: a meta-analysis |
| Q51363927 | Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. |
| Q47822693 | Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance. |
| Q42439814 | Increasing glucagon secretion could antagonize the action of exogenous insulin for glycemic control in streptozocin-induced diabetic rhesus monkeys |
| Q51382361 | Independent relationships of obesity and insulin resistance with serum proinsulin level in prepubertal children with normal glucose tolerance. |
| Q24336156 | Interleukin-6 regulates pancreatic alpha-cell mass expansion |
| Q35043457 | Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women |
| Q43925391 | Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study |
| Q37567856 | Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction. |
| Q92092609 | Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes |
| Q93209111 | Periodontitis affects glucoregulatory hormones in severely obese individuals |
| Q47243992 | Pro-inflammatory cytokines after an episode of acute pancreatitis: associations with fasting gut hormone profile |
| Q51374590 | Proinsulin and the proinsulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulation. |
| Q60920909 | Relationship Between Fasting Plasma Glucagon Level and Renal Function-A Cross-Sectional Study in Individuals With Type 2 Diabetes |
| Q37973276 | The potential role of glutamate in the current diabetes epidemic. |
| Q38245233 | The role of glucagon on type 2 diabetes at a glance. |
Search more.